Get notified of page updates
Federal Public Policy Initiatives
Review some of FORCE's current legislative and regulatory policy priorities that impact the hereditary cancer community.

Stay up to date on research and information

Sign Up for FORCE Newsletters

Policy Archive

Fraud Alert! Genetic Test Scams are a Growing Problem

Genetic Counseling & Testing

September 27, 2019 - Federal law enforcement agencies recently charged 35 individuals associated with dozens of telemedicine companies and cancer genetic testing laboratories for fraudulent genetic testing and Medicare billing practices. Scams are a growing problem. If you are considering DNA/genetic testing, there is important information that you should know first.

See this recent fraud alert issued by the Office of Inspector General and learn how you can protect yourself from fraud, misinformation, and harm.

Scam Alert SignThere is a flood of information available about genetic tests for cancer risk in the media, and even at community events, such as health fairs and senior centers. Genetic testing can provide important, life-saving information when done in the right way. If you are considering genetic testing to learn more about your hereditary cancer risk, or if you have already received genetic test results, consider speaking with a genetic counselor, doctor or other health care provider who has advanced training in genetics. This is the most reliable way to obtain and understand information about your risk.

View a detailed graphic of the fraud scheme

Watch this brief video about genetic testing fraud.

Read the FORCE Blogs on this issue for more information and perspective: 

Filing a Complaint

You have a right to know the name of the lab performing your genetic testing. Beware of representatives marketing tests in community settings or selling genetic tests for unnamed labs. Genetic tests are currently regulated by the FDA and CLIA. When ordering lab work such as a genetic test, healthcare providers typically order them through a trusted, CLIA-certified lab, which is regularly evaluated for quality assurance.

The FDA aims to ensure that test marketing materials and claims are accurate, and that they address the information needs of the approved audience—healthcare providers or the public. If you have concerns or a complaint about a laboratory, you or your health care provider can file a complaint.

CLIA
All clinical laboratory testing performed on humans in the U.S. (except in clinical trials and basic research) is overseen by the Clinical Laboratory Improvement Amendments (CLIA).

If you have concerns or want to file a complaint against a lab that conducted genetic testing, you or your healthcare provider should reach out to your state CLIA contact

All other questions or concerns about the CLIA program should be submitted to [email protected]

FDA
The Food and Drug Administration (FDA) also tracks adverse (negative) events and concerns about laboratory tests through MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Patients or healthcare providers can report adverse events to the FDA.

Take Action Now Become an Advocate 2024 Priorities Federal Policy State Policy Advocacy Archive

News Briefs

10/7/2024 - Urged congressional leadership to swiftly pass the SCREENS for Cancer Act, which would reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) for another five years,

10/2/2024 - Joined the Alliance for Connected Care and over 150 orgs in a letter to CMS/HHS encouraging the development of a permanent policy related to telehealth practitioners and the reporting of their location at the time of service.

9/25/2024 - Sent a letter to members of the Senate Judiciary Committee strongly opposing efforts to advance S. 2140, the Patent Eligibility Restoration Act (PERA), which would allow patents on abstract ideas, laws of nature, and natural phenomena.

More